140 related articles for article (PubMed ID: 25134355)
1. [The role of cellular senescence in carcinogenesis and antitumor therapy].
Mosieniak G; Strzeszewska A
Postepy Biochem; 2014; 60(2):194-206. PubMed ID: 25134355
[TBL] [Abstract][Full Text] [Related]
2. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
Roninson IB; Broude EV; Chang BD
Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684
[TBL] [Abstract][Full Text] [Related]
3. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts.
Volonte D; Zhang K; Lisanti MP; Galbiati F
Mol Biol Cell; 2002 Jul; 13(7):2502-17. PubMed ID: 12134086
[TBL] [Abstract][Full Text] [Related]
4. Cellular senescence and cancer treatment.
Schmitt CA
Biochim Biophys Acta; 2007 Jan; 1775(1):5-20. PubMed ID: 17027159
[TBL] [Abstract][Full Text] [Related]
5. Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo.
Hu Z; Zhang D; Hao J; Tian K; Wang W; Lou H; Yuan H
Cancer Chemother Pharmacol; 2014 Feb; 73(2):397-407. PubMed ID: 24322375
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells.
Huang B; Deo D; Xia M; Vassilev LT
Mol Cancer Res; 2009 Sep; 7(9):1497-509. PubMed ID: 19737973
[TBL] [Abstract][Full Text] [Related]
7. Cancer, aging and cellular senescence.
Campisi J
In Vivo; 2000; 14(1):183-8. PubMed ID: 10757076
[TBL] [Abstract][Full Text] [Related]
8. Bexarotene induces cellular senescence in MMTV-Neu mouse model of mammary carcinogenesis.
Shilkaitis A; Bratescu L; Green A; Yamada T; Christov K
Cancer Prev Res (Phila); 2013 Apr; 6(4):299-308. PubMed ID: 23430755
[TBL] [Abstract][Full Text] [Related]
9. Hallmarks of senescence in carcinogenesis and cancer therapy.
Shay JW; Roninson IB
Oncogene; 2004 Apr; 23(16):2919-33. PubMed ID: 15077154
[TBL] [Abstract][Full Text] [Related]
10. [Senescence and cellular immortality].
Trentesaux C; Riou JF
Bull Cancer; 2010 Nov; 97(11):1275-83. PubMed ID: 21051314
[TBL] [Abstract][Full Text] [Related]
11. Senescence as biologic endpoint following pharmacological targeting of receptor tyrosine kinases in cancer.
Francica P; Aebersold DM; Medová M
Biochem Pharmacol; 2017 Feb; 126():1-12. PubMed ID: 27574725
[TBL] [Abstract][Full Text] [Related]
12. Cellular senescence in the development and treatment of cancer.
Saretzki G
Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
[TBL] [Abstract][Full Text] [Related]
13. What has senescence got to do with cancer?
Dimri GP
Cancer Cell; 2005 Jun; 7(6):505-12. PubMed ID: 15950900
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-treated cancer cells show mitotic disturbances leading to growth arrest and induction of senescence phenotype.
Mosieniak G; Sliwinska MA; Przybylska D; Grabowska W; Sunderland P; Bielak-Zmijewska A; Sikora E
Int J Biochem Cell Biol; 2016 May; 74():33-43. PubMed ID: 26916504
[TBL] [Abstract][Full Text] [Related]
15. Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity.
Özcan S; Alessio N; Acar MB; Toprak G; Gönen ZB; Peluso G; Galderisi U
Oncotarget; 2015 Nov; 6(37):39482-92. PubMed ID: 26498687
[TBL] [Abstract][Full Text] [Related]
16. Induction of senescent-like growth arrest as a new target in anticancer treatment.
Wang X; Tsao SW; Wong YC; Cheung AL
Curr Cancer Drug Targets; 2003 Apr; 3(2):153-9. PubMed ID: 12678717
[TBL] [Abstract][Full Text] [Related]
17. To clear, or not to clear (senescent cells)? That is the question.
Lujambio A
Bioessays; 2016 Jul; 38 Suppl 1():S56-64. PubMed ID: 27417123
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence: a double-edged sword in the fight against cancer.
Ohtani N; Takahashi A; Mann DJ; Hara E
Exp Dermatol; 2012 Jul; 21 Suppl 1():1-4. PubMed ID: 22626462
[TBL] [Abstract][Full Text] [Related]
19. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer.
Tato-Costa J; Casimiro S; Pacheco T; Pires R; Fernandes A; Alho I; Pereira P; Costa P; Castelo HB; Ferreira J; Costa L
Clin Colorectal Cancer; 2016 Jun; 15(2):170-178.e3. PubMed ID: 26603055
[TBL] [Abstract][Full Text] [Related]
20. Double staining of β-galactosidase with fibrosis and cancer markers reveals the chronological appearance of senescence in liver carcinogenesis induced by diethylnitrosamine.
Pacheco-Rivera R; Fattel-Fazenda S; Arellanes-Robledo J; Silva-Olivares A; Alemán-Lazarini L; Rodríguez-Segura M; Pérez-Carreón J; Villa-Treviño S; Shibayama M; Serrano-Luna J
Toxicol Lett; 2016 Jan; 241():19-31. PubMed ID: 26589970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
